Literature DB >> 15302943

Hepatitis C virus NS5A: tales of a promiscuous protein.

Andrew Macdonald1, Mark Harris1.   

Abstract

The non-structural 5A (NS5A) protein of hepatitis C virus (HCV) has been the subject of intensive research over the last decade. It is generally accepted that NS5A is a pleiotropic protein with key roles in both viral RNA replication and modulation of the physiology of the host cell. Our understanding of the role of NS5A in the virus life cycle has been hampered by the lack of a robust in vitro system for the study of HCV replication, although the recent development of the subgenomic replicon has at least allowed us to begin to dissect the involvement of NS5A in the process of viral RNA replication. Early studies into the effects of NS5A on cell physiology relied on expression of NS5A either alone or in the context of other non-structural proteins; the advent of the replicon system has allowed the extrapolation of these studies to a more physiologically relevant cellular context. Despite recent progress, this field is controversial, and there is much work to be accomplished before we fully understand the many functions of this protein. In this article, the current state of our knowledge of NS5A, discussing in detail its direct involvement in virus replication, together with its role in modulating the cellular environment to favour virus replication and persistence, are reviewed. The effects of NS5A on interferon signalling, and the regulation of cell growth and apoptosis are highlighted, demonstrating that this protein is indeed of critical importance for HCV and is worthy of further investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302943     DOI: 10.1099/vir.0.80204-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  135 in total

Review 1.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Oxidative stress and apoptosis in hepatitis C: the core issue.

Authors:  Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

3.  GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression.

Authors:  Robert T Rydze; Jinhua Xiang; James H McLinden; Jack T Stapleton
Journal:  J Infect Dis       Date:  2012-04-25       Impact factor: 5.226

Review 4.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 5.  The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis.

Authors:  Dongsheng Li; Ting Wei; Catherine M Abbott; David Harrich
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 6.  Viral proteins and Src family kinases: Mechanisms of pathogenicity from a "liaison dangereuse".

Authors:  Mario Angelo Pagano; Elena Tibaldi; Giorgio Palù; Anna Maria Brunati
Journal:  World J Virol       Date:  2013-05-12

Review 7.  Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.

Authors:  Megha Haridas Upadya; Jude Juventus Aweya; Yee-Joo Tan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 8.  Hepatitis C virus infection and apoptosis.

Authors:  Richard Fischer; Thomas Baumert; Hubert-E Blum
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 9.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

Review 10.  Interaction of hepatitis C virus with the type I interferon system.

Authors:  Friedemann Weber
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.